WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹30 Cr | ₹27 Cr | ₹0.11 Cr | ₹0.44 Cr | ₹6.12 Cr |
What is the latest Total Debt ratio of WINDLAS BIOTECH ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹30 Cr |
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹0.11 Cr |
| Mar2023 | ₹0.44 Cr |
| Mar2022 | ₹6.12 Cr |
How is Total Debt of WINDLAS BIOTECH Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹30 Cr | 10.17 | |
| Mar2025 | ₹27 Cr | 24,777.98 | |
| Mar2024 | ₹0.11 Cr | -75.45 | |
| Mar2023 | ₹0.44 Cr | -92.75 | |
| Mar2022 | ₹6.12 Cr | - | |
Compare Total Debt of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,807.1 Cr | -0.7% | -19.8% | -0.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.7% |
-19.8% |
-0.5% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses